Table 4 Secondary outcome scores
|
Experimental Group n = 35 |
Control Group n = 39 | Between-group difference over time | |
|---|---|---|---|
| Mean ± SD (out of 10) | Mean ± SD (out of 10) | Mean (95 % CI), ES (95 % CI) | |
|
Baseline Self-efficacy HRQoL |
5.83 ± 2.57 0.36 ± 0.34 |
5.92 ± 2.24 0.38 ± 0.32 | |
|
Week 6 Self-efficacy HRQoL |
7.36 ± 2.33* 0.65 ± 0.31 |
5.73 ± 1.96 0.44 ± 0.30 |
1.72(0.42, 3.0), ES = 0.76(0.28, 1.22) 0.23(0.6, 0.4), ES = 0.69(0.21, 1.15) |
|
Week 12 Self-efficacy HRQoL |
6.95 ± 2.30 0.60 ± 0.32** |
5.51 ± 2.00 0.36 ± 0.35 |
1.53 (0.38, 2.7), ES = 0.67(0.3, 1.13) 0.26(0.06, 0.46), ES = 0.71(0.24, 1.18) |
|
Month 6 Self-efficacy HRQoL |
7.19 ± 2.12 0.55 ± 0.34 |
6.00 ± 1.93 0.37 ± 0.34 |
1.28(0.32, 2.2), ES = 0.59(0.12, 1.05) 0.2(0.05, 0.35), ES = 0.53(0.06, 0.99) |